Efficacy and Safety of Gepotidacin as Treatment of Uncomplicated Urogenital Gonorrhea (EAGLE-1): Design of a Randomized, Comparator-Controlled, Phase 3 Study.

Perry, Caroline R; Scangarella-Oman, Nicole E; Millns, Helen; Flight, William; Gatsi, Sally; Jakielaszek, Charles; Janmohamed, Salim; Lewis, David A

Perry, Caroline R; Scangarella-Oman, Nicole E; Millns, Helen; Flight, William; Gatsi, Sally; Jakielaszek, Charles; Janmohamed, Salim; Lewis, David A.

Affiliation

Perry CR; GSK, 1250 S. Collegeville Road, Collegeville, PA, 19486-0989, USA. caroline.r.perry@gsk.com.
Scangarella-Oman NE; GSK, 1250 S. Collegeville Road, Collegeville, PA, 19486-0989, USA.
Millns H; GSK, Stevenage, UK.
Flight W; GSK, London, UK.
Gatsi S; GSK, 1250 S. Collegeville Road, Collegeville, PA, 19486-0989, USA.
Jakielaszek C; GSK, 1250 S. Collegeville Road, Collegeville, PA, 19486-0989, USA.
Janmohamed S; GSK, London, UK.
Lewis DA; Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Infect Dis Ther ; 12(9): 2307-2320, 2023 Sep.

Article in En | MEDLINE | ID: mdl-37751016

Key words

Antibiotics; Gepotidacin; Gonorrhea; Neisseria gonorrhoeae; Phase 3 clinical trial; Study design

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Guideline Language: En Journal: Infect Dis Ther Year: 2023 Document type: Article Affiliation country: United States Country of publication: New Zealand

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google